We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

The Startup Turning Yeast Into Psychedelics
Industry Insight

Technology Networks recently spoke with Nick Milne, co-founder and CSO at Octarine to learn more about what science says on the therapeutic benefits of psychedelic compounds, why a bio-based approach for manufacturing is advantageous and the challenges associated.

Read More

Three Definitely Isn't a Crowd When It Comes to Protein Complex Analysis
Industry Insight

In a study published in Cell Reports, members of the Washburn Lab described their three-pronged approach to analyzing protein complexes – affinity tag protein purification, chemical crosslinking with high-resolution mass spectrometry and computational molecular modeling with protein docking. We interviewed Washburn to find out more.

Read More

More Sensitive COVID-19 Testing Using Droplet Digital PCR
Industry Insight

We recently spoke with experts at Bio-Rad to learn more about the reasons for, and significance of, false negative test results, and how the use of a more sensitive test could help to reduce this problem.

Read More

Ensuring High-quality Cancer Care During the COVID-19 Pandemic
Industry Insight

Technology Networks recently had the pleasure of speaking to Dr Sandeep “Bobby” Reddy, Chief Medical Officer of NantHealth to gain a better understanding of the impact COVID-19 is having on the treatment of cancer. Reddy discusses what is currently known, in terms of risk and severity of SARS-CoV-2 infection in individuals with cancer, and elaborates on the innovative approaches that have been adopted by oncologists to enable continuation of high-quality care during the pandemic.

Read More

Finding the Best Cells for Faster Drug Discovery
Industry Insight

Advances in developing cell-based therapeutics and products require time-consuming and laborious cell-by-cell manipulation and analysis. Berkeley Lights Inc provide research and development services to help accelerate this process and make it more efficient via their proprietary technology. Technology Networks recently spoke with Mark White, Sr. Director of Marketing, Berkeley Lights Inc to find out more.

Read More

The Need for Broader Testing of COVID-19 Patients
Industry Insight

Diagnostic testing is playing a crucial role in global efforts to tackle the COVID-19 pandemic. By identifying infected individuals, efficient isolation and contact tracing can take place. However, what role could broader testing of COVID-19 patients have?

Read More

A "Plant Paternity Test" To Limit Global Food Wastage
Industry Insight

Dr Wirulda Pootakham is a Thai entrepreneur who has created a "plant paternity test" – HybridSure – which enables seed production companies to assess the genetic purity of hybrid seeds faster than traditional methods.

Read More

Want To Volunteer for a COVID-19 Trial? This Tool Can Help Connect You
Industry Insight

To try and make the process of applying for COVID-19 clinical trials easier, a free public health initiative called World Without COVID has been launched that will link users with all the trials they are eligible for.

Read More

Startup Collaborates With the Francis Crick Institute To Model COVID-19's Spread Between (and Within) People
Industry Insight

London-based engineering startup Hadean, in collaboration with researchers at the Francis Crick Institute, hopes to use its simulation solution, the Aether Engine, to better model the spread of COVID-19 both between and within people. We spoke to Hadean’s Vice President of Operations, Mimi Keshani, to find out more.

Read More

Exploring the Potential of Antibody–Drug Conjugates
Industry Insight

The UK registered and self-funding charity LifeArc has several antibody–drug conjugate (ADC) programs in the oncology and non-oncology space. Technology Networks recently had the pleasure of speaking with Dr Laura Murch, Scientist at LifeArc, to learn more about ADCs. She highlights some of the antibody characterization assays they have developed to identify candidate ADCs, and touches on the regulatory success of ADCs.

Read More

 
Advertisement